Coronavirus disease 2019 and renal transplantation
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved..
Ever since the severe acute respiratory syndrome virus causing coronavirus disease 2019 (COVID-19) struck the world, global health strategies have changed significantly. According to the Centers for Disease Control and Prevention, kidney transplant recipients are stratified as being high risk of developing fatal illness from COVID-19 infection. Kidney transplant is the gold-standard treatment for end-stage kidney disease subjects. During the pandemic, significant concerns have emerged regarding continuation of kidney transplant surgeries and management of kidney transplant recipients post-transplant. The added risk of immunosuppression in this cohort was and remains a theoretical concern, posing a potential risk of transplantation rather than benefit. This comprehensive review aims to cover most of the faced challenges in kidney transplantation in different stages of the pandemic. In addition, it will elucidate the epidemiology, nature, course of the disease, surgical consideration in donors and recipients as well as role of immunosuppression and management of COVID-19 infected kidney transplant recipients during these extraordinary circumstances.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
World journal of clinical cases - 9(2021), 27 vom: 26. Sept., Seite 7986-7997 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nassar, Mahmoud [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 09.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.12998/wjcc.v9.i27.7986 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331628597 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331628597 | ||
| 003 | DE-627 | ||
| 005 | 20231225213859.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.12998/wjcc.v9.i27.7986 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM331628597 | ||
| 035 | |a (NLM)34621855 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nassar, Mahmoud |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus disease 2019 and renal transplantation |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a Ever since the severe acute respiratory syndrome virus causing coronavirus disease 2019 (COVID-19) struck the world, global health strategies have changed significantly. According to the Centers for Disease Control and Prevention, kidney transplant recipients are stratified as being high risk of developing fatal illness from COVID-19 infection. Kidney transplant is the gold-standard treatment for end-stage kidney disease subjects. During the pandemic, significant concerns have emerged regarding continuation of kidney transplant surgeries and management of kidney transplant recipients post-transplant. The added risk of immunosuppression in this cohort was and remains a theoretical concern, posing a potential risk of transplantation rather than benefit. This comprehensive review aims to cover most of the faced challenges in kidney transplantation in different stages of the pandemic. In addition, it will elucidate the epidemiology, nature, course of the disease, surgical consideration in donors and recipients as well as role of immunosuppression and management of COVID-19 infected kidney transplant recipients during these extraordinary circumstances | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Kidney failure | |
| 650 | 4 | |a Renal transplantation | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Nso, Nso |e verfasserin |4 aut | |
| 700 | 1 | |a Ariyaratnam, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Sandhu, Jasmine |e verfasserin |4 aut | |
| 700 | 1 | |a Mohamed, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Baraka, Bahaaeldin |e verfasserin |4 aut | |
| 700 | 1 | |a Ibrahim, Atif |e verfasserin |4 aut | |
| 700 | 1 | |a Alfishawy, Mostafa |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bhangoo, Harangad |e verfasserin |4 aut | |
| 700 | 1 | |a Soliman, Karim M |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Rizzo, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Daoud, Ahmed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of clinical cases |d 2013 |g 9(2021), 27 vom: 26. Sept., Seite 7986-7997 |w (DE-627)NLM233331727 |x 2307-8960 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:27 |g day:26 |g month:09 |g pages:7986-7997 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.12998/wjcc.v9.i27.7986 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 27 |b 26 |c 09 |h 7986-7997 | ||